SEC Form 4Coverage since Jun 8, 2026
$TNXP insider trading
Over the last 12 months, Tonix Pharmaceuticals Holding insiders reported 3 buys totaling $132K and no sales across SEC Form 4 filings.
- Bought · 12m
- $132K 3 events
- Sold · 12m
- — 0 events
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $TNXP · 12Mvia TradingView
Top insiders · 12m
LEDERMAN SETHChief Executive Officer1× · $59K
Stillwell Richard Newcomb—1× · $58K
Taylor Carolyn E.—1× · $15K
All insider trades
3 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | Taylor Carolyn E.D | ▲ Buy | 1,415 | $10.55 | $15K | +338.5% | — |
| Jun 9, 2026 | LEDERMAN SETHChief Executive Officer · O·D | ▲ Buy | 5,000 | $11.79 | $59K | +124.8% | — |
| Jun 8, 2026 | Stillwell Richard NewcombD | ▲ Buy | 5,000 | $11.65 | $58K | — | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TNXP feed.